We are live on ! Find out more
ACM

Adalta Capital Management Portfolio holdings

AUM $209M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
+19.54%
3 Year Est. Return
+66.34%
5 Year Est. Return
+69.73%
10 Year Est. Return
–
AUM
$140M
AUM Growth
-$1.45M
Cap. Flow
-$8.82M
Cap. Flow %
-6.3%
Top 10 Hldgs %
40.19%
Holding
88
New
7
Increased
21
Reduced
12
Closed
8

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$2.54M
2
BOX icon
Box
BOX
+$1.83M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$761K
4
BABA icon
Alibaba
BABA
+$637K
5
WFC icon
Wells Fargo
WFC
+$588K

Top Sells

Rank Stock Value
1
FMI
Foundation Medicine, Inc.
FMI
+$16.9M
2
PHG icon
Philips
PHG
+$478K
3
PAC icon
Grupo Aeroportuario del Pacifico
PAC
+$444K
4
TSM icon
TSMC
TSM
+$439K
5
KNDI
Kandi Technologies Group
KNDI
+$348K

Sector Composition

Rank Sector Weight
1 Financials 18.49%
2 Technology 15.38%
3 Industrials 13.66%
4 Consumer Discretionary 13.16%
5 Energy 10.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CL icon
51
Colgate-Palmolive
CL
$71.9B
$580K 0.41%
8,660
– –
VZ icon
52
Verizon
VZ
$198B
$571K 0.41%
10,687
– –
MOMO
53
Hello Group
MOMO
$879M
$526K 0.38%
12,000
– –
HON icon
54
Honeywell
HON
$78.2B
$518K 0.37%
3,447
– –
APTV icon
55
Aptiv
APTV
$12.1B
$512K 0.37%
+6,100
New +$557K
LH icon
56
Labcorp
LH
$24.9B
$505K 0.36%
3,381
-350
-9% -$53.2K
DOV icon
57
Dover
DOV
$27.7B
$501K 0.36%
5,650
– –
JPM.WS
58
DELISTED
JPMorgan Chase
JPM.WS
$493K 0.35%
6,775
-1,400
-17% -$103K
ESGR
59
DELISTED
Enstar Group
ESGR
$484K 0.35%
2,322
– –
ESTR
60
DELISTED
Estre Ambiental, Inc.
ESTR
$474K 0.34%
78,885
– –
RDNT icon
61
RadNet
RDNT
$5.25B
$454K 0.32%
30,181
+16,861
+127% +$241K
T icon
62
AT&T
T
$162B
$433K 0.31%
17,066
– –
OAK
63
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$422K 0.3%
10,187
+3,200
+46% +$132K
CRCM
64
DELISTED
CARE.COM, INC.
CRCM
$415K 0.3%
+18,785
New +$376K
APO icon
65
Apollo Global Management
APO
$74.6B
$401K 0.29%
11,604
+2,300
+25% +$80.2K
VAC icon
66
Marriott Vacations Worldwide
VAC
$3.35B
$394K 0.28%
+3,515
New +$415K
PG icon
67
Procter & Gamble
PG
$338B
$343K 0.24%
4,125
– –
TTE icon
68
TotalEnergies
TTE
$194B
$290K 0.21%
4,450
– –
BIIB icon
69
Biogen
BIIB
$29.8B
$283K 0.2%
800
– –
NBIS
70
Nebius Group N.V.
NBIS
$54B
$263K 0.19%
+8,000
New +$271K
CELG
71
DELISTED
Celgene Corp
CELG
$238K 0.17%
+2,665
New +$236K
GILD icon
72
Gilead Sciences
GILD
$163B
$232K 0.17%
3,000
– –
MXIM
73
DELISTED
Maxim Integrated Products
MXIM
$225K 0.16%
3,992
-1,153
-22% -$69.5K
MLM icon
74
Martin Marietta Materials
MLM
$32.6B
$218K 0.16%
1,200
– –
SYRS
75
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$190K 0.14%
1,593
– –
1 2
3
4

Similar funds

GCM
Glynn Capital Management Menlo Park, California $209M AUM 31.14% 1-Year Est. Return
BCM
Beartown Capital Management Huntington Woods, Michigan $209M AUM
AL
ADE LLC Baltimore, Maryland $209M AUM 15.13% 1-Year Est. Return
MIM
Marshall Investment Management Littleton, Colorado $208M AUM 30.96% 1-Year Est. Return
BSCCG
Blue Sky Capital Consultants Group Poway, California $210M AUM 28.65% 1-Year Est. Return
EM
ELCO Management New York $208M AUM 23.85% 1-Year Est. Return
GHP
Great Hill Partners Boston, Massachusetts $210M AUM 134.81% 1-Year Est. Return
GP
Geneva Partners Lake Geneva, Wisconsin $208M AUM 72.91% 1-Year Est. Return

Adalta Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Adalta Capital Management held 88 positions worth $140M, down 1% from $142M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Adalta Capital Management withdrew a net $8.82M in Q3 2018, closing 8 positions and reducing 12 holdings. Its most notable exit was Foundation Medicine, Inc., an estimated $16.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.

Against the trend, Adalta Capital Management opened a new position in Teva Pharmaceuticals worth $707K.

  • Adalta Capital Management's largest Q3 2018 buy was Teva Pharmaceuticals: 32,800 shares worth $707K.
  • Adalta Capital Management added most to Stellantis in Q3 2018, an estimated $2.54M increase.
  • Adalta Capital Management's biggest Q3 2018 reduction was Forest City Realty Trust, Inc., cutting an estimated $265K.
  • Adalta Capital Management fully exited Foundation Medicine, Inc. in Q3 2018, selling an estimated $16.9M.
  • Adalta Capital Management's ten largest holdings make up 40% of its $140M portfolio in Q3 2018.
  • Adalta Capital Management opened 7 new positions and closed 8 in Q3 2018.
  • Adalta Capital Management's portfolio value fell 1% quarter-over-quarter to $140M.

Based on Adalta Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.